In conclusion, the present results show that CK18 (M30) is a predictor of the FLI suspected NAFLD, confirming that the FLI is an independent predictor of a high 10-year CV risk according to both the FRS and the SCORE2 algorithm. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.